Eisai Co., Ltd. ( ESALF) - Stock Earnings
ESALF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 109.7 million USD | 1.4 billion USD |
| 2026Q1 | -20.5 million USD | 1.3 billion USD |
| 2026Q2 | 111.3 million USD | 1.4 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ESALF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 280.1 million USD | 4.9 billion USD |
| 2025 | 310.9 million USD | 5.3 billion USD |
| 2026 | 242.9 million USD | 5.2 billion USD |
| 2026 Est. | — | — |
ESALF
Price: $30.61
Dividend Yield: 3.37%
Forward Dividend Yield: 3.34%
Payout Ratio: 132.31%
Dividend Per Share: 1.02 USD
Earnings Per Share: 0.87 USD
P/E Ratio: 33
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Market Capitalization: 8.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 40
DGR3: 8.90%
DGR5: 3.87%
DGR10: 3.25%
DGR20: 7.31%